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Figure S1: Cluster analysis of GFP+ cells (related to Fig. 1)  
(A) Probability distribution of distances between neighboring GFP+ events 
measured on d2-d3 after RCAS injection. (B) Representative maps of traced 
GFP+ events used for analysis in (A); green triangles: C cell clusters; blue 
triangles: NSCs). (C) Number of GFP+ clones (C cell clusters or NSCs) found per 
whole-mount on d2-d3 after RCAS injection at P21. (D) C cells per GFP+ clone 
(single cells or clusters). Clones initially increase in size but then decrease (d2 
vs. d5 p < 0.0001****; d5 vs. d7 p= 0.0116*.; one-way ANOVA with Tukey’s 
multiple comparisons). Note that on d2, several C cell clusters consist of one cell 
only, consistent with a single integration event during M phase. The largest 
clusters can be found at d5 and one-cell clusters re-appear. (E) At later time-
points clusters contain of few Ascl1+ cells and are surrounded by large numbers 
of GFP+ neuroblasts, possibly their own progeny (upper panel; d6). Other 
clusters do not contain neuroblasts (lower panel; d5). (F) GFP+ C cells (white 
arrowheads) in a cluster with comparable number of unlabeled C cells (black 
arrowheads). (G) A cluster of three GFP+ASCL1+ cells and one NSCl on d5 
(arrowhead). Scale bar is 500 µm in (B), all others are 20 µm. 
 

Figure S2: NSCs undergo symmetric consuming divisions (related to Fig. 3) 
(A) Experimental outline for (B-C): Time-mated pregnant Nestin::CreERT2;Ai14 
mice received one low dose of Tx at E17.5 and V-SVZ whole-mounts of the 
offspring were prepared at P21 (B) or P60 (C). The majority of tdT+ clusters at 
P21 were devoid of NSCs (B) whereas a few were mixed (B’; black arrowhead 
denotes the NSC body; white arrowhead denotes the basal process). (C) A C cell 
cluster devoid of NSCs at P60. (G) Experimental outline for (H-K): P21 
hGFAP::CreERT2;Ai14 mice received Tx and BrdU (drinking water) for 1, 3 or 7d 
prior analysis in whole-mount preparations. (H-J) Clusters of tdT+BrdU+ C cells 
devoid of NSCs, indicating symmetric consuming (differentiation) divisions. (K) 
Graph shows that the number of tdT+BrdU+ C cell clusters per whole-mount 
(bars with mean +/- SD; left y-axes) does not change from d1 to d3 to d7 while 
the percentage of C cell clusters/tdT+ NSCs (percentage of consuming divisions 
of tdT+ NSCs) increases over time (line plot; right y-axes). (L) 
CLEAVED_CASPASE-3 staining in whole-mounts of P60 hGFAP::GFP mice 
revealed low levels of cell death among NSCs (GFAP::GFP+) or C cells 
(ASCL1+). Scale bars: 20 µm; asterisks indicate blood vessels revealed by 
antibodies raised in mouse (ASCL1) used on unperfused tissue; x in (C) 
indicates a tdT+ ependymal cell located at the apical surface. 		

Figure S3: NSC behavior in vivo and ex vivo (related to Figure 4) 
(A-B) Effects of culture conditions on V-SVZ explants. (A) Density of KI67+ cells 
(cells/mm2*10-2) after 1 or 4 days in organotypic explants vitro (DIV) is 
comparable to that in vivo but decreases at 5DIV (p= 0.013 *; two-tailed student’s 
t-test with equal variance). Data are represented as mean +/- SD. (A’) 
Immunostainings for KI67 of explants drop-fixed (in vivo), after 2 or 4DIV, or 5DIV 
under hypoxic or normoxic conditions. Note: normoxic conditions lead to a more 
severe reduction in the densities of proliferating cells. (B) Typical chain migration 
of DCX+ neuroblasts seen in vivo is disrupted in cultured explants at 2DIV. (C-F) 
Live-imaging of cells in V-SVZ explants. (C) Experimental outline for (D-F): 
Postnatal hGFAP::CreERT2;Ai14 or hGFAP::CreERT2;Ai14;FucciS/G2/M mice 
received one injection of Tx; thin slivers of whole-mount preparations were 
prepared after 2 days, imaged for up to 4 days (also see (A)), and fixed and 
processed for immunohistochemistry. (D) Levels of proliferation (Fucci) remained 
constant during live imaging. Data are represented as mean +/- SD. (E) Lineage 
progression of C cells. C cells divided approximately once a day. Divisions are 
indicated by horizontal lines, cells followed during imaging by vertical lines 
(missing vertical lines: cells could not be followed any further). (F) A tdT+ cell 
with NSC morphology retracts the prominent process (arrowhead) over time, and 
then divides. Both daughter cells are GFAP+ and KI67+ in post-imaging 
immunohistochemistry. (G-H) In vivo: tdT+ NSCs in whole-mounts from 
hGFAP::CreERT2;Ai14 mice (three days after Tx and BrdU). (G) A NSC in contact 
with BrdU+ cells and neuroblasts. (H) A tdT+ NSC contacts blood vessels 
(green) and ASCL1+ cells (green) with its lateral processes (H’) and with one of 
the basal processes (H’’) (Note: whereas most NSCs have one basal process, 
some are bifurcated and harbor two basal processes). Scale bars: 100 µm (A’); 
50 µm (B); 20 µm (G-H&F); 10 µm (F’&H”). x in (B) indicates a tdT+ ependymal 
cell; asterisks indicate blood vessels revealed by antibodies raised in mouse 
(Ascl1). 
 	

Figure S4: Mathematical modeling of V-SVZ dynamics and neurogenesis (related 
to Figure 5) 
(A) Population dynamics of B1 cells and neurogenesis rate in base-line (B1) 
mathematical model. Upper graph: B1 cell number (blue); lower graph: 
neurogenesis (red). Cell number estimated from experimental data (see Fig. 5D) 
is indicated as dots, model prediction as lines. (B) Population dynamics of B1 
and B2 cell populations (upper graph) in a revised mathematical (B2) model 
based on the rates of neurogenesis seen in vivo (Fig. 5D) (lower graph). Data are 
represented as mean +/- SD.  

Figure S5: B1 cells give rise to B2 cells (related to Figure 6) 
(A) Experimental outline for (B-E): Postnatal hGFAP::Tva mice were injected 
intraventricularly with RCAS-GFP retrovirus and V-SVZ whole-mounts were 
prepared after 4 weeks. (B) A mixed GFP+ cluster consisting of ASCL1+ C cells, 
neuroblasts, and a NSC (arrowhead). (C) A triplet of GFP+ cells: one cell is a B1 
cell in contact with the LV (C’ and yellow arrow in C”) whereas two other cells 
appear to be without apical contact (white arrows in C”). (C”) shows 3D view of 
cells in (C). Note the lack of a long basal process of the apical B1 cells shown in 
(C’). (D) A pair of non-apical GFP+ cells contacting blood vessels (BV, 
arrowheads in D’). (E) A non-apical GFP+ cell contacting blood vessels (BV, 
arrowhead in E’ lower panel) and expressing GFAP (E’). (F) Experimental outline 
for (G): Postnatal hGFAP::GFP mice received two i.p. injections of 3H-thymidine 
per day for 7d. Ultrathin (TEM) coronal sections were analyzed after 4 weeks. (G) 
Pseudo-colored serial TEM micrographs of a 3H-thymidine+ LRC 
(autoradiography not shown) contacting the LV (black arrowheads). (G’) Apical 
contact boxed in (G) containing the primary cilium (white arrowhead) and its 
daughter centriole (black arrowheads). Scale bars: 15 µm (C”), 2 µm (G), 500 nm 
(G’); all others 20 µm. 

Figure S6: Sporadic reactivation of GFAP+ NSCs (related to Figure 7) 
(A) Experimental outline for (B,C): Postnatal hGFAP::Tva mice were injected 
intraventricularly with RCAS-GFP retrovirus and 4 weeks later received one daily 
injection of Tx for 5 days. Coronal sections of the OB were prepared 4 weeks 
later. (B) A GFP+tdT+ granule neuron born from a reactivated GFAP+GFP+ cell. 
(C) Percentage of GFP+tdT+ OB interneurons born 4 weeks (or later) after viral 
injection at P21. (D) Experimental outline for (E): Postnatal hGFAP::CreERT2;Ai14 
mice received BrdU (drinking water) for one week (P21-P28) and one daily 
injection of Tx for five days after different intervals (simultaneously (sim) or 
immediately after (0wk) BrdU, or 2, 4, 8, 12, or 16 weeks after BrdU). Coronal 
sections of the OB were prepared 4 weeks after the last Tx injection. (E) 
Percentages of BrdU+tdT+ interneurons generated from cells recombining the 
Ai14 reporter when Tx was given after the different intervals indicated on the X-
axis (4wk vs. 8wk, p= 0.04*; 4wk vs. 12 wk, p= 0.0004***; 4wk vs 16 wk, p= 
0.004**; one-tailed student’s t-test with equal variance). Data are represented as 
mean +/- SD. Scale bar: 15 µm; white arrows in B indicate GFP+tdT+NEUN+ 
interneurons. 			
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Table S1: Summary of modes of division (related to Figs. 1-3) 
 
all events C clusters  mix. clusters   B1 cell pairs  B1 cells 
 
short-term lineage tracing 
CREERT2 d3  (18) 
83%  
(15/18) 
0  
(0/18) 
17%  
(3/18) nd 
RCAS d2-d3  (75) 
75%  
(56/75) 
0 
(0/75) 
6%  
(1/18) 
25%  
(18/75) 
RCAS d4-d7  (97) 
85%  
(82/97) 
1% / 7% 
(1/82 C) 
(1/15 B) 
27%  
(4/15) 
15%  
(15/97) 
 
long-term lineage tracing 
 
RCAS 2 wks 
 
(16) 
88%  
(7/8) 
12%  
(1/8) 
25%  
(2/8) (8) 
 
RCAS 4 wks 
 
(37) 
63%  
(5/8) 
37.5% / 10% 
(3/8 C) 
(3/29 B) 
14%  
(4/29) (29) 
CREERT2  
(E17.5- P21) 
 
(11) 
70%  
(8/11) 
30%  
(3/11) nd nd 
 Mathematical modeling 
 
                            consumption                             symmetric self-renewal  
                                     
                                     70%                                                   30% 
 
 
 
 
Table S1: Summary of modes of division (related to Figs. 1-3) 
Summary of the modes of division observed in postnatal lineage-tracing 
experiments (RCAS or CREERT2) and predicted by mathematical modeling. For 
short-term experiments (d1-d7), ratios of divisions generating one or two NSCs to 
those generating clusters of progeny were analyzed. For long-term lineage 
tracing, cluster composition was analyzed. Data indicated in italics refer to 
findings whose interpretation is less clear (see text for details). Indicated are 
percentages of occurrences; total event counts are given in parenthesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2: Short-term RCAS-based lineage tracings (related to Figs. 1 & 2) 
whole-
mount day Sample 
GFP+ B1 
cells 
(secondary) 
GFP+ B1 
cell pairs 
(tertiary) 
Clusters  Cluster size (cells/cluster)  and composition 
1 2 1293 0 0 1 5 C 
2 2 1433 1 0 3 1 C, 1 C, 2 C  
3 2 1433c 0 0 1 3 C 
4 2 1428 0 1 0 0 
5 2 no2d2 2 0 10 1 C, 4 C, 2 C, 4 C, 5 C, 3 C, 2 C, 2 C, 5 (3 C+2A), 7 (5C+2A) 
6 2 no4d2 2 0 10 2,1,1,1,1,2,2,4,2,5 (all C) 
7 2 no3d2 1 0 11 1,4,4,1,2,4,2,1,2,3,5 (all C) 
8 3 1298 0 0 3 2 C, 4 C, 2 C 
9 3 1427 2 0 1 8 (6 C + 2 A) 
10 3 1429 0 0 0 0 
11 3 no2d3 1 0 3 2 C, 2 C, 4 C 
12 3 no1d3 0 0 2 3 C, 2 C 
13 3 no3d3 2 0 2 2 C, 2 C 
14 3 5076 5 0 3 3 C, 4 C, 2 C 
15 3 5075 1 0 6 2 C, 1 C, 3 C, 4 C, 2 C, 2C 
16 3 5081 0 0 0 0 
17 4 1350 0 0 3 8 C, 9 C, 4 (2 C + 2 A) 
18 4 1352 1 0 1 2 C 
19 4 1348 0 0 1 6 C 
20 5 no3d5 0 1 6 3 C, 5 (4 C + 1 A), 4 C, 2 C, 8 C, 1 C 
21 5 no1d5 3 1 16 4,4,2,2,15,10,2,5,6,10,2,2,2,7,16,5 (all C) 
22 5 no1cd5 1 0 5 6 C, 12 C, 4 C, 4 C, 5 (1B+4C; mixed cluster) 
23 5 no2d5 1 0 5 9,2,2,6,4 (all C) 
24 6 no41d6 1 0 7 4,6,4,2,8,6,5 (all C) 
25 6 no41cd6 0 0 1 3 C 
26 6 no42d6 0 0 2 2 C, 2 C 
27 6 no42cd6 0 0 5 2 C, 2 C, 10 (8C + 2 A), 2 C, 3 C 
28 6 no39d6 0 0 10 2,4,2,1,2,6,5,4,4,4 (all C) 
29 7 no2d7 2 0 0 0 
30 7 no4d7 0 0 1 4 C 
31 7 no3d7 1 1 12 8,4,4,4,1,1,1,1,2,2,1,2 (all C) 
32 7 no1d7 1 1 7 5,1,4,3,2,6,3 (all C) 
 
Table S2: Short-term RCAS-based lineage tracings (related to Figs. 1 & 2) 
RCAS-GFP was injected into hGFAP::Tva mice at P21 and GFP+ cells per V-
SVZ whole-mount were quantified after two to seven days (day = days after 
RCAS injection; Clusters = C cell-only clones or clones containing C cells and A 
cells clearly associated with the cluster; migrating A cells are excluded from 
further analysis). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S3: Short-term CREERT2-based lineage tracings (related to Fig. 3) 
whole-
mount Sample 
tdT+  
B1 
cells 
tdT+BrdU+ B1 
cells 
tdT+BrdU+ B1 
cell pairs  
tdT+BrdU+ 
clusters  
Cluster size 
(cells/cluster) and 
composition 
1 1578 38 2 1 2 8 C, 15 C 
2 1575 26 4 0 2 7 C, 8 C 
3 1570 62 4 1 0 0 
4 1575 20 0 0 1 4 C 
5 1572 58 3 1 3 2 C, 2 C, 2 C 
6 1582 106 9 0 2 18 C, 2 C 
7 1583 55 1 0 1 4 C 
8 1578 100 6 0 4 4 C, 4 C,8 C, 5 C 
9 1649 21 0 0 0 0 
 
Table S3: Short-term CREERT2-based lineage tracings (related to Fig. 3) 
Tamoxifen (6.66 mg/Kg BW) was injected into hGFAP::CreERT2;Ai14 mice at P21 
and mice received BrdU three days before analysis. Cells labeled by tdT or 
tdT/BrdU were quantified per V-SVZ whole-mount (Clusters = C cell-only clones 
or clones containing C cells and A cells clearly associated with the cluster; 
migrating A cells are excluded from further analysis). 
 
 
 
 
 
 
 
 
Table S4: Short-term CREERT2-based lineage tracings (related to Fig. 3) 
whole-
mount day Sample 
tdT+  
B1 
cells 
tdT+BrdU+ 
B1 cells 
tdT+BrdU+ 
B1 cell pairs 
tdT+BrdU+ 
clusters  
Cluster size 
(cells/cluster) 
and composition 
ratio tdT+ 
B1 cells/C 
clusters 
1 1 1454 20 1 0 0 0 - 
2 1 1455 3 0 0 0 0 - 
3 1 1449R 21 2 0 2 3 C, 3 C 10.5 
4 1 1449L 14 2 0 2 4 C, 1 C 7 
5 3 1324R 12 1 0 1 2 C 12 
6 3 1324L 17 3 0 1 1 C 17 
7 3 1322 19 2 0 1 8 C 19 
8 3 1285 16 0 0 0 0 - 
9 3 1276 5 0 0 1 6 A cells (excluded) 5 
10 3 1274R 5 0 0 0 0 - 
11 3 1274L 12 0 0 0 0 - 
12 3 1571 14 1 0 0 0 - 
13 3 1569 15 2 0 0 0 - 
14 3 1647 4 0 0 1 16 C 4 
15 3 1652 5 0 0 0 0 - 
16 7 773R 12 2 0 0 0 - 
17 7 773L 9 1 0 2 
26 (18 C + 8 
A), 6A 
(excluded) 
4.5 
18 7 775R 3 1 0 0 0 - 
19 7 775L 1 0 0 1 10 C 1 
20 7 777R 1 ? 0 1 5 C 1 
21 7 777L 1 0 0 0 0 - 
22 7 3 1 0 0 0 0 - 
23 7 4R 7 3 0 0 0 - 
24 7 4L 2 0 0 0 0 - 
25 7 5 3 0 0 0 0 - 
26 7 6 1 0 0 0 0 - 
27 7 8 1 0 0 0 0 - 
28 7 757R 13 2 0 0 0 - 
29 7 757L 9 nd - 1 12 (8 C + 4 A) 9 
30 7 762 3 nd - 2 7 C, 6 C 1.5 
31 7 763R 3 nd - 0 0 - 
32 7 763L 6 nd - 1 17 (4 C+13 A) 6 
33 7 753 4 nd - 0 0 - 
34 7 758 5 nd - 3 
13 C, 10 A 
(excluded), 5 A 
(excluded) 
1.7 
35 7 3 8 3 0 1 13 C 8 
 
Table S4: Short-term CREERT2-based lineage tracings (related to Fig. 3) 
Tamoxifen (1.67-3.33 mg/Kg BW) was injected into hGFAP::CreERT2;Ai14 mice at 
P21 and mice received BrdU for one, three, or seven days before analysis. Cells 
labeled by tdT or tdT/BrdU were quantified per V-SVZ whole-mount (Clusters = C 
cell-only clones or clones containing C cells and A cells clearly associated with 
the cluster; migrating A cells are excluded from further analysis). 
 
 
 
 
 
 
 
 
Table S5: Distribution of GFP+ cells in the OB (related to Fig. 6) 
region\sample #732 #767 #765 #768 #731 #766 %GFP+  
total GFP+/OB 160 93 203 227 411 64 - 
PGL 5 4 3 1 nd nd 2.34 +/- 0.86 
GCL 138 81 168 222 nd nd 88.48 +/- 3.25 
deep GCL 85 69 148 209 nd nd 73.07 +/- 7.96 
superf. GL 53 12 20 13 nd nd 15.4 +/- 6.09 
IPL 3 0 0 0 nd nd 0.47 +/- 0.47 
mitral 6 0 2 0 nd nd 1.18 +/- 0.89 
EPL 1 1 1 0 nd nd 0.55 +/- 0.22 
core 7 2 16 4 nd nd 4.04 +/- 1.4 
core, A cells 0 6 12 0 nd nd 3.09 +/- 1.79 
 
Table S5: Distribution of GFP+ cells in the OB (related to Fig. 6) 
The OBs from hGFAP::Tva mice that had received RCAS-GFP at P21 and BrdU 
at P49-P55 were analyzed four weeks after BrdU administration for the presence 
of GFP+ cells. Shown are the numbers of GFP+ cells in serial sections and their 
layer distribution. The percentages of GFP+ cells found in specific layers are 
shown in bold. PGL periglomerular layer; GCL granule cell layer; IPL internal 
plexiform layer; EPL external plexiform layer. 
 
 
 
 
 
 
 
Table S6: Distribution of GFP+BrdU+ cells in the OB (related to Fig. 6) 
region\sample #732 #767 #765 #768 #731 #766 %GFP+ BrdU+  
total GFP+BrdU+/OB 8 11 11 11 11 2 - 
PGL 0 0 0 0 nd nd 0 
GL 8 10 11 11 nd nd 97.73 +/- 2.27 
deep GCL 4 9 10 10 nd nd 78.41 +/- 9.71 
superf. GCL 4 1 1 1 nd nd 19.32 +/- 10.23 
IPL 0 0 0 0 nd nd 0 
mitral 0 0 0 0 nd nd 0 
EPL 0 0 0 0 nd nd 0 
core 0 1 0 0 nd nd 2.28 +/- 2.28 
core, A cells  0 0 0 0 nd nd 0 
 
Table S6: Distribution of GFP+BrdU+ cells in the OB (related to Fig. 6) 
The OBs from hGFAP::Tva mice that had received RCAS-GFP at P21 and BrdU 
at P49-P55 were analyzed 4 weeks after BrdU administration for the presence of 
GFP+BrdU+ cells. Shown are the numbers of GFP+BrdU cells in serial sections 
and their layer distribution. The percentages of GFP+BrdU+ cells found in 
specific layers are shown in bold. PGL periglomerular layer; GCL granule cell 
layer; IPL internal plexiform layer; EPL external plexiform layer.  	
Supplementary movies 
Movie S1: A self-renewing NSC maintains its prominent (basal) process during 
division (related to Fig. 5B) 
A tdT+ NSC divides ex vivo and generates a daughter cell with NSC morphology 
that grows a prominent process in parallel to the process of its mother cell. 
Images acquired every 35 minutes. Time is in hh:mm:ss. 
  
Movie S2: A self-renewing NSC maintains its prominent (basal) process and 
outgrowth additional processes during division (related to Fig. 5C) 
A tdT+ NSCl divides ex vivo and generates a daughter cell with NSC 
morphology. Images acquired every 35 minutes. Time is in hh:mm:ss. 
  
  
 			
